These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 194844)
21. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains. Fresen KO; Hausen H Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026 [TBL] [Abstract][Full Text] [Related]
22. Induction of Epstein-Barr virus early antigen by phytohaemagglutinin in the presence of 5-iodo-2'-deoxyuridine: application to EBV serology. Lenoir G; Tovey MG; Lavoue MF J Immunol Methods; 1980; 34(1):23-9. PubMed ID: 6252264 [TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. Qualtiere LF; Pearson GR Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099 [TBL] [Abstract][Full Text] [Related]
24. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids. Klein G; Clements G; Zeuthen J; Westman A Cancer Lett; 1977 Jul; 3(1-2):91-8. PubMed ID: 196751 [TBL] [Abstract][Full Text] [Related]
25. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns. Klein G; Zeuthen J; Ber R; Ernberg I J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188 [TBL] [Abstract][Full Text] [Related]
26. Abortive expression of the Epstein-Barr virus (EBV) cycle in a variety of EBV DNA-containing cell lines, as reflected by nucleic acid hybridization in situ. Moar MH; Klein G Int J Cancer; 1979 Nov; 24(5):679-87. PubMed ID: 93584 [TBL] [Abstract][Full Text] [Related]
27. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment. Shapiro IM; Andersson-Anvret M; Klein G Intervirology; 1978; 10(2):94-101. PubMed ID: 209000 [TBL] [Abstract][Full Text] [Related]
28. Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia. Sairenji T; Spiro RC; Reisert PS; Paquin L; Sakamoto K; Shibuya A; Sullivan JL; Katayama I; Humphreys RE Am J Hematol; 1983 Dec; 15(4):361-74. PubMed ID: 6316777 [TBL] [Abstract][Full Text] [Related]
29. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines. Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333 [TBL] [Abstract][Full Text] [Related]
30. Host cell regulation of induction of Epstein-Barr virus. Glaser R; Nonoyama M J Virol; 1974 Jul; 14(1):174-6. PubMed ID: 4365330 [TBL] [Abstract][Full Text] [Related]
31. Activation of Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells with propionic acid and with culture fluids of propionic acid-producing anaerobes. Kishishita M; Yanase S; Ito Y Cancer Lett; 1982; 16(2):117-20. PubMed ID: 6290028 [TBL] [Abstract][Full Text] [Related]
32. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate]. Furukawa M; Kato C; Kamide M; Umeda R Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb; 92(2):189-93. PubMed ID: 2545850 [TBL] [Abstract][Full Text] [Related]
33. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D Intervirology; 1975; 5(6):319-34. PubMed ID: 181343 [TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus. Takada K; Fujiwara S; Yano S; Osato T Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479 [TBL] [Abstract][Full Text] [Related]
35. Column separation of viral capsid antigen (VCA)-positive cells from VCA-negative cells in an Epstein-Barr virus (EBV)-producing lymphoid line, Dalianis T; Klein G; Andersson B Int J Cancer; 1977 Apr; 19(4):460-7. PubMed ID: 191413 [TBL] [Abstract][Full Text] [Related]
36. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye. Sairenji T; Hinuma Y Int J Cancer; 1980 Sep; 26(3):337-42. PubMed ID: 6270005 [TBL] [Abstract][Full Text] [Related]
37. Interferon enhances the expression of epstein-Barr virus early antigen in Daudi cells. Tovey MG; Dron M; Gresser I J Gen Virol; 1982 May; 60(Pt 1):31-8. PubMed ID: 6178801 [TBL] [Abstract][Full Text] [Related]
39. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus. Klein G; Falk L; Falk K Intervirology; 1978; 10(3):153-64. PubMed ID: 210135 [TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases. Joncas JH; Wills A; Reece E; Fox Z Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]